Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
批准号:
10926690
负责人:
Liqiang Xi
金额:
$65.13万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AmericanBasic ScienceBiological AssayBiomedical ResearchCCRCertificationChromosomal DuplicationChromosomal translocationClinicalClinical ProtocolsClinical ResearchClinical TrialsCollaborationsCommunitiesDevelopmentDiagnosticDiagnostic ServicesEligibility DeterminationEventFluorescent in Situ HybridizationFormalinGene RearrangementGliomaGoalsHematologic NeoplasmsImmunologyKnowledgeLaboratoriesLungLymphomaMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of thoraxModernizationMolecularOncogenesOperative Surgical ProceduresParaffin EmbeddingPathologyPatientsPediatric OncologyPharmaceutical PreparationsProtocols documentationResearchResearch PersonnelResourcesSolid NeoplasmSurgical PathologyTestingTherapeuticTransplantationUnited States National Institutes of HealthUrologic OncologyVaccinesbench to bedsidecancer genomicscancer therapychemotherapyclinical diagnosticsclinically significantcollegecostdesigndetection testimprovedmalignant breast neoplasmmolecular diagnosticsmolecular pathologyneuro-oncologynovel diagnosticspersonalized diagnosticsprecision medicineprognosticresearch clinical testingstandard of caretargeted treatment
中文摘要
病理实验室的FISH实验室是CCR,NCI支持积极的NCI临床方案的宝贵资源。该部门为CCR研究人员提供临床诊断服务,采用荧光原位杂交(FISH)CLIA/CAP测试,以支持外科病理学诊断和测试患者的NCI临床方案资格。更重要的是,该实验室代表着一座从床到床的桥梁,与生物医学研究的最新发现保持同步,比参考实验室更快地将新发现带给临床患者测试。FISH实验室目前在NCI支持16项临床试验。这包括来自CCR调查人员整个社区的请求:神经肿瘤科、胸胃恶性肿瘤科、疫苗科、儿科肿瘤科、实验移植和免疫科、外科科、泌尿外科肿瘤科、主任办公室。主动测试菜单包括对实体肿瘤和血液系统恶性肿瘤中具有临床意义的染色体易位和扩增事件的FISH分析。FISH实验室积极参与与CCR和其他NIH研究所内的其他研究人员的研究合作,以推进基础和临床研究。
英文摘要
The FISH Lab in the Laboratory of Pathology is a valuable resource at CCR, NCI to support active NCI clinical protocols. The section provides clinical diagnostic service for CCR investigators with Fluorescence In Situ Hybridization (FISH) CLIA/CAP testing in support of Surgical Pathology diagnostics and testing patients for NCI clinical protocol eligibility. More importantly, the laboratory represents a bench-to-bedside bridge that keeps pace with the latest discoveries in biomedical research, bringing new discoveries to clinical patient testing more rapidly than would be available from reference laboratories. The FISH Lab currently supports 16 clinical trials at the NCI. That includes requests from the entire community of CCR investigators: Neuro-Oncology Branch, Thoracic & GI Malignancies Branch, Vaccine Branch, Pediatric Oncology Branch, Experimental Transplantation and Immunology Branch, Surgery Branch, Urologic Oncology Branch, Office of the Director. The active test menu includes FISH assays for clinically significant chromosomal translocations and amplification events in solid tumors and hematologic malignancies. The FISH Lab actively participates in research collaborations with other investigators within the CCR and other NIH Institutes to advance basic and clinical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service
-
批准号:10926694
-
项目类别:
-
资助金额:$755.48万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
Molecular Diagnostics Core Laboratory
-
批准号:10703044
-
项目类别:
-
资助金额:$206.89万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
-
批准号:10703114
-
项目类别:
-
资助金额:$103.45万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
NCI COMPASS
-
批准号:10262815
-
项目类别:
-
资助金额:$648.03万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
Molecular Diagnostics Core Laboratory
-
批准号:10262749
-
项目类别:
-
资助金额:$239.68万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
Molecular Diagnostics Core Laboratory
-
批准号:10487234
-
项目类别:
-
资助金额:$90.35万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
Molecular Diagnostics Core Laboratory
-
批准号:10926618
-
项目类别:
-
资助金额:$481.94万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service
-
批准号:10703118
-
项目类别:
-
资助金额:$839.07万
-
财政年份:--
-
负责人:Liqiang Xi
-
依托单位:
海外基金